BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11576344)

  • 1. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
    Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
    Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
    Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
    Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide modulates vascular disease in the remnant kidney model.
    Kang DH; Nakagawa T; Feng L; Johnson RJ
    Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Ratajska A; Dembińska-Kieć A
    J Vasc Res; 2001; 38(3):288-300. PubMed ID: 11399901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.
    Kang DH; Hughes J; Mazzali M; Schreiner GF; Johnson RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1448-1457. PubMed ID: 11423573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor attenuates trauma-induced injury in rats.
    Campbell B; Chuhran C; Lefer AM
    Br J Pharmacol; 2000 Jan; 129(1):71-6. PubMed ID: 10694204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy.
    Zhou XJ; Laszik Z; Ni Z; Wang XQ; Brackett DJ; Lerner MR; Silva FG; Vaziri ND
    Lab Invest; 2000 Jul; 80(7):1079-87. PubMed ID: 10908153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF(165) mediates glomerular endothelial repair.
    Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
    J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new model of renal microvascular endothelial injury.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Adler S; Kurokawa K; Couser WG; Johnson RJ
    Kidney Int; 1997 Jul; 52(1):182-94. PubMed ID: 9211361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Dembińska-Kieć A
    J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.
    Shao J; Miyata T; Yamada K; Hanafusa N; Wada T; Gordon KL; Inagi R; Kurokawa K; Fujita T; Johnson RJ; Nangaku M
    J Am Soc Nephrol; 2001 Oct; 12(10):2088-2097. PubMed ID: 11562407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
    Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
    Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the mechanism of vascular endothelial growth factor improvement of ischemic flap survival in rats.
    Pang Y; Lineaweaver WC; Lei MP; Oswald T; Shamburger S; Cai Z; Zhang F
    Plast Reconstr Surg; 2003 Aug; 112(2):556-64. PubMed ID: 12900614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
    Vriese AS; Tilton RG; Elger M; Stephan CC; Kriz W; Lameire NH
    J Am Soc Nephrol; 2001 May; 12(5):993-1000. PubMed ID: 11316858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors.
    Ostendorf T; Van Roeyen C; Westenfeld R; Gawlik A; Kitahara M; De Heer E; Kerjaschki D; Floege J; Ketteler M
    J Am Soc Nephrol; 2004 Sep; 15(9):2307-19. PubMed ID: 15339980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy.
    Hohenstein B; Braun A; Amann KU; Johnson RJ; Hugo CP
    Nephrol Dial Transplant; 2008 Apr; 23(4):1144-56. PubMed ID: 18045820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.